Europe Spine Biologics Market Research Report - Segmented By Product Type, By Surgery Type & By Country(UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends & Forecasts (2025 to 2033)

Updated On: June, 2024
ID: 4120
Pages: 145

Europe Spine Biologics Market Size

The Europe Spine Biologics Market Size was valued at USD 717.98 million in 2024. The Europe Spine Biologics Market Size is expected to have 4.3% CAGR from 2025 to 2033 and be worth USD 1048.75 million by 2033 from USD 748.85 million in 2025.  

Spine biologics are used during spine fusion surgery for the treatment of spinal deformities such as trauma, tumors, degenerative disc disease, and spinal cord injuries by stimulating bone growth formation through the inflammatory stage, repair stage, and remodeling stage. Biologics help in faster recovery and activate cellular growth. Therefore, the surge in the number of spinal fusion surgeries has fueled the adoption of biologics.

Spine Biologics market is growing due to advancement in technology as well as demand for better minimally surgical procedures, which make it more convenient for both the patient and doctor. Factors such as a rise in the prevalence of diseases due to the aging population and increased government funding are also driving the overall market. The major factors restraining the growth of the market are the high healthcare costs for such procedures, lack of expert professionals and unfavorable reimbursement scenarios.

The bone grafts substitute segment accounted for a major share of the market. 

KEY MARKET PLAYERS

Key players operating in the Europe Spine Biologics Market profiled in this report are Alphatec Holdings, Inc., Depuy Synthes (Johnson & Johnson), Exactech, Inc., Globus Medical, Inc., Medtronic plc, NuVasive, Inc., Orthofix International N.V., RTI Surgical, Inc., SeaSpine, and Zimmer Biomet Holdings, Inc.

MARKET SEGMENTATION

This research report on the Europe Spine Biologics Market has been segmented and sub-segmented into the following categories

By Product Type

  • platelet Rich Plasma
  • Bone Graft
  • Bone Graft Substitutes
  • Bone Marrow Aspirate Therapy

By Surgery Type

  • Transforaminal Lumbar Interbody Fusion
  • Anterior Lumbar Interbody Fusion
  • Lateral Lumbar Interbody Fusion
  • Anterior Cervical Discectomy And Fusion
  • Posterior Lumbar Interbody Fusion
  • Others

By Country

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Please wait. . . . Your request is being processed

Anil Kumar P is research manager at Market Data Forecast and responsible for Healthcare Domain.

Author

Anil Kumar P (Research Manager - Healthcare)

Anil Kumar P is the lead author of this report and the manager of the team responsible for authoring healthcare reports at Market Data Forecast. He holds a Bachelor’s degree in Pharmacy (Hons.) from BITS Pilani, one of India’s premier institutions. Over the past seven years, Anil has gained extensive experience working with multiple market research companies, where he has collaborated with a diverse range of clients—from innovative startups to Fortune 500 companies—delivering data-driven insights and strategic advice that drive business growth.

Read More

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample